Coagulation System in Acute Renal Failure

  • Alain Kanfer


Intravascular coagulation (IC) undoubtedly takes place in many forms of acute renal failure (ARF), although its pathogenetic role and importance are still a matter of debate. Conversely, acute uremia per se provokes disturbances of the hemostatic system, with concomitant bleeding and a hypercoagulable tendency. In this chapter, we will deal successively with these two aspects.


Acute Renal Failure Disseminate Intravascular Coagulation Hemolytic Uremic Syndrome Disseminate Intravascular Coagulation Thrombotic Thrombocytopenic Purpura 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kincaid-Smith P. Coagulation and renal disease. Kidney Int 2: 183–190, 1972.PubMedCrossRefGoogle Scholar
  2. 2.
    Wardle EN. Fibrin in renal disease: Functional considerations. Clin Nephrol 2: 85–92, 1974.PubMedGoogle Scholar
  3. 3.
    Levinsky NG. Pathophysiology of acute renal failure. N Engl J Med 196: 1453–1458, and 1977.CrossRefGoogle Scholar
  4. 4.
    Hostetter TH, Wilkes BM, Brenner BM. Mechanisms of impaired glomerular filtration in acute renal failure. In Acute Renal Failure, Brenner BM, Stein JH. (eds). New York; Churchill Livingstone, 1980, pp. 52–78.Google Scholar
  5. 5.
    Schrier RW, Gardenswartz MH, Burke TJ. Insuffisance rénale aiguë: Pathogénie, diagnostic et traitement. In Actualités Néphrologiques de l’hopital Necker. Paris; Flammarion, 1980, pp. 205–230.Google Scholar
  6. 6.
    Levinsky NG, Alexander EA, Venkatachalam MA. Acute renal failure. In The Kidney, Brenner BM, Rector FC Jr (eds). Philadelphia: WB Saunders, 1981, pp. 1181–1236.Google Scholar
  7. 7.
    Shuman MA, Majerus PW. The measurement of thrombin in clotting blood by radioimmunoassay. J Clin Invest 58: 1249–1258, 1976.PubMedCrossRefGoogle Scholar
  8. 8.
    Herrmann RP, Bailey PE. Plasma thrombin assay using a chromogenic substrate in disseminated intravascular coagulation due to snake bite envenomation. Thrombos Haemostas 41: 544–552, 1979.Google Scholar
  9. 9.
    Colman RW, Robboy SJ, Minna JD. Disseminated intravascular coagulation: An approach. Amer J Med 52: 679–689, 1972.PubMedCrossRefGoogle Scholar
  10. 10.
    Siegal T, Seligsohn U, Aghai E, Modan M. Clinical and laboratory aspects of disseminated intravascular coagulation: A study of 118 cases. Thrombos Haemostas 39: 122–134, 1978.Google Scholar
  11. 11.
    Spero JA, Lewis JH, Hasiba U. Disseminated intravascular coagulation findings in 346 patients. Thrombos Haemostas 43: 28–33, 1980.Google Scholar
  12. 12.
    Whitaker AN. Acute renal failure in disseminated intravascular coagulation. Progr Biochem Pharmacol 9: 45–64, 1975.Google Scholar
  13. 13.
    Whitaker AN, Bunce I, Nicoll P, Dowling SV. Interaction of angiotensin with disseminated intravascular coagulation. A possible mechanism in the genesis of acute renal failure. Amer J Path 72: 1–12, 1973.PubMedGoogle Scholar
  14. 14.
    Rammer L, Gerdin B. Protection against the impairment of renal function after intravascular coagulation by increased ingestion of sodium chloride. Nephron 14: 433–441, 1975.PubMedCrossRefGoogle Scholar
  15. 15.
    Beller K. The role of endotoxin in disseminated intravascular coagulation. In Disseminated Intravascular Coagulation, Mammen EF, Anderson GF, Barhartt MI (eds). Stuttgart: FK Schattauer, 1969, pp. 124–149.Google Scholar
  16. 16.
    Graeff H, Mitchell PS, Beller FK. Fibrinolytic enzyme system of the kidney related to renal functionafter infusion of endotoxin in rabbits. Lab Invest 19: 169–173, 1968.Google Scholar
  17. 17.
    Lee L. Antigen-antibody reaction in the pathogenesis of bilateral renal cortical necrosis. J Exp Med 117: 365–376, 1963.PubMedCrossRefGoogle Scholar
  18. 18.
    Semeraro N. Interactions of platelets, leucocytes and endothelium with bacterial endotoxins: Possible relevance to kidney disorders. In Hemostasis, Prostaglandins and Renal Disease, Remuzzi G, Mecca G, de Gaetano G (eds). New York: Raven Press, 1980, pp. 99–116.Google Scholar
  19. 19.
    Robbins J, Stetson CA. An effect of antigen-antibody interaction on blood coagulation. J Exp Med 109: 1–8, 1959.PubMedCrossRefGoogle Scholar
  20. 20.
    Mueller-Eckhardt C, Luscher EF. Immune reactions of human blood platelets. Thrombos Diathes Haemorrh 20: 155–167, 1968.Google Scholar
  21. 21.
    Kaplan AP, Gigli I, Austen KF. Immunologic activation of Hageman factor and its relationship to fibrinolysis, bradykinin generation and complement. J Clin Invest 50: 51, 1971.Google Scholar
  22. 22.
    Wardle N, Wright NA. Intravascular coagulation and glycerin hemoglobinuric acute renal failure. Arch Pathol 95: 271–275, 1973.PubMedGoogle Scholar
  23. 23.
    Carvalho JS, Carvalho ACA, Vaillancourt RA, Page LB, Colman RW, Landewehr DM, Oken DE. The pathogenetic@ significance of intravascular coagulation in experimental acute renal failure. Nephron 22: 484–491, 1978.PubMedCrossRefGoogle Scholar
  24. 24.
    Corrigan JJ. Effects of anticoagulating and non-anticoagulating concentration of heparin on the generalized Shwartzman reaction. Thrombos Diathes Haemorrh 24: 136–145, 1970.Google Scholar
  25. 25.
    Margaretten W, Csavossy I, McKay DG. An electron microscopic study of thrombin-induced disseminated intravascular coagulation. Blood 29: 169–181, 1967.PubMedGoogle Scholar
  26. 26.
    Bergstein JM, Michael AF. Renal cortical fibrinolytic activity in the rabbit following one or two doses of endotoxin. Thrombos Diathes Haemorrh 29: 27–32, 1973.Google Scholar
  27. 27.
    Muller-Berghaus G, McKay DG. Prevention of the generalized Shwartzman reaction in pregnant rats by adrenergic blocking agents. Lab Invest 17: 276–280, 1967.PubMedGoogle Scholar
  28. 28.
    Bolton WK, Atuk NO. Study of chemical sympathectomy in endotoxin-induced lethality and fibrin deposition. Kidney Int 13: 263–270, 1978.PubMedCrossRefGoogle Scholar
  29. 29.
    Stahl E, Gerdin B, Rammer L. Protective effect of angiotensin II inhibition on acute renal failure after intravascular coagulation in the rat. Nephron 29: 250–257, 1981.PubMedCrossRefGoogle Scholar
  30. 30.
    Haanen C, Holdrinet A, Wijdeweld P. Intravascular clotting and acute renal failure. In Pathogenesis and clinical findings with renal failure, Gessler U, Schroeder K, Weindinger H (eds). Stuttgart: Georg Thieme, 1971, pp. 132–139.Google Scholar
  31. 31.
    Zech P, Beruard M, Ducluzeau R, Moskovtchenko JF, Berthet P, Traeger J. Evolution des insuffisances renales aigues avec coagulation intravasculaire. J Urol Nephrol (Paris), 78: 337–341, 1972.Google Scholar
  32. 32.
    Kleinknecht D, Kanfer A, Josso F. Intravascular coagulation and heparin therapy in acute renal failure: A reappraisal. Europ J Clin Biol Res 17: 695–700, 1972.Google Scholar
  33. 33.
    Josso F, Cosson A, Girot R, Gazengel C. Coagulation intravasculaire et nephropathies. In Actualités Néphrologiques de l’Hopital Hecker. Paris: Flammarion, 1973, pp. 181–200.Google Scholar
  34. 34.
    Conte J, Delsol J, Mignon-Conte M, Ton-That H, Suc JM. Insuffisance rénale aigue et coagulation intravasculaire. In Actualités Néphrologiques de l’Hopital Necker. Paris: Flammarion, 1973, pp. 202–206.Google Scholar
  35. 35.
    Larcan A, Lambert H, Laprevote-Heully MC, Alexandre P, Gerbaux A. Insuffisances rénales aigues et coagulopathies de consommation au cours de l’état gravido-puerpéral. Sem Hop, Paris, 54: 595–601, 1978.Google Scholar
  36. 36.
    Schneider CL, Engstrom RM. Experimental pulmonary arterial occlusions: Acute cor pulmonale simulating “obstetrical shock” of late pregnancy. Amer J Obstet Gynec 68: 691–705, 1954.PubMedGoogle Scholar
  37. 37.
    Bayley T, Clements JA, Osbahr AJ. Pulmonary and circulatory effects of fibrinopeptides. Circ Res 21: 469–485, 1967.PubMedGoogle Scholar
  38. 38.
    Manwaring BA, Thorning D, Curreri PW. Mechanism of acute pulmonary dysfunction induced by fibrinogen degradation product D. Surgery 84: 45–54, 1978.PubMedGoogle Scholar
  39. 39.
    Kleinknecht D, Grunfeld JP, Cia-Gomez P, Moreau JF, Garcia-Torres R. Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int 4: 390–400, 1973.PubMedCrossRefGoogle Scholar
  40. 40.
    Gralnick HR, Marchesis, Givelber H. Intravascular coagulation in acute leukemia: Clinical and subclinical abnormalities. Blood 40: 709–707, 1972.PubMedGoogle Scholar
  41. 41.
    Kleinknecht D, Verger D, Mignon F, Richet G. Insuffisance rénale et pancréatite aigue. Signification des dépôts fibrino’Bdes intraglomérulaires. Ann Med Int 121: 17–28, 1970.Google Scholar
  42. 42.
    Pritchard JA, Weisman R, Ratnoff OD, Vosburgh GJ. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med 250: 89–98, 1954.PubMedCrossRefGoogle Scholar
  43. 43.
    Vardi J, Fields GA. Microangiopathic hemolytic anemia in severe pre-eclampsia. Amer J Obstet Gynec 119: 617–622, 1974.PubMedGoogle Scholar
  44. 44.
    Grunfeld JP, Ganeval D, Bournerias E. Acute renal failure in pregnancy. Kidney Int 18: 179–191, 1980.PubMedCrossRefGoogle Scholar
  45. 45.
    Clarkson AR, McDonald MK, Fuster V, Cash JD, Robson JS. Glomerular coagulation in acute ischemic renal failure. Quart J Med 39: 585–599, 1970.PubMedGoogle Scholar
  46. 46.
    Haanen C, Novakova I, Wijdeveld P, Van Lieberger F. Significance of fibrin split products in patients with renal failure. Scand J Haemat Suppl 13: 345–350, 1971.Google Scholar
  47. 47.
    Hedner U, Nilsson IM. Clinical experience with determination of fibrinogen degradation products. Acta Med Scand 189: 471–477, 1971.PubMedCrossRefGoogle Scholar
  48. 48.
    Hedner U, Nilsson IM. Maladies du rein et produits de dégradation de la fibrine. In Actualités Néphrologiques de l’Hopital Necker, Paris: Flammarion, 1973, pp. 257–285.Google Scholar
  49. 49.
    Donati MB, Molla A, Michiesen P, Vermylen J. Measurement of urinary fibrinogen related material: Methodological aspects. J Lab Clin Med 83: 921–936, 1974.PubMedGoogle Scholar
  50. 50.
    Vreeken J, Boom-Gaard J, Deggeler K. Urokinase excretion in patients with renal disease. Acta Med Scand 180: 15–157, 1966.Google Scholar
  51. 51.
    Koffler D, Paronetto F. Fibrinogen deposition in acute renal failure. Amer J Path 49: 383–395, 1966.PubMedGoogle Scholar
  52. 52.
    Benshay Z. Contributions to renal pathology through the use of electron microscope. Israel J Med Sci 3: 191–198, 1967.Google Scholar
  53. 53.
    Solez K, Morel-Maroger L, Sraer JD. The morphology of “acute tubular necrosis” in man: Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 58: 362–376, 1979.PubMedCrossRefGoogle Scholar
  54. 54.
    Antonovych T. Bilateral cortical necrosis. In Controversies in Nephrology, Schreiner GE (eds). Washington DC: Georgetown University, 1979, pp. 513–519.Google Scholar
  55. 55.
    Vassalli P, Richet G. Nécrose corticale et Insuffisance rénale aigue des états de choc. In Comptesrendus du 1er Congrès International de Néphrologie, Richet G (ed). Basel: Karger, 1961, pp. 236–302.Google Scholar
  56. 56.
    Sraer JD, Blanc E, Delarue F, Kanfer A, Ardaillou R, Richet G. Effect of calcium and hydrogen ion on the fibrinolytic activity of isolated renal glomeruli from rat. Kidney Int 15: 238–245, 1979.PubMedCrossRefGoogle Scholar
  57. 57.
    Corrigan JJ, Jordan CM. Heparin therapy in septicemia with disseminated intravascular coagulation. N Engl J Med 283: 778–782, 1970.PubMedCrossRefGoogle Scholar
  58. 58.
    Clarkson AR, Lawrence JR, Meadows R, Seymour AE. The hemolytic uremic syndrome in adults. Quart J Med 39: 227–244, 1970.PubMedGoogle Scholar
  59. 59.
    Sraer JD, Morel-Maroger L, Beaufils P, Ardaillou N, Helenon C, Richet G. Les insuffisances renales aigues d’origine vasculaire. J Uron Néphrol (Paris) 78: 317–329, 1972.Google Scholar
  60. 60.
    Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET. The hemolytic-uremic syndrome. Nephron 11: 174–192, 1973.PubMedCrossRefGoogle Scholar
  61. 61.
    Goldstein MH, Churg J, Strauss L, Gribetz D. Hemolytic-uremic syndrome. Nephron 23: 263–272, 1979.PubMedCrossRefGoogle Scholar
  62. 62.
    Editorial. Hemolytic uremic syndrome of young women. Lancet 1: 943-944, 1976.Google Scholar
  63. 63.
    Kanfer A, Morel-Maroger L, Solez K, Sraer JD, Richet G. The value of renal biopsy in hemolytic-uremic syndrome in adults. In Hemostasis, Prostaglandins and Renal Disease, Remuzzi G, Mecca G, de Gaetano G (eds). New York: Raven Press, 1980, pp. 399–406.Google Scholar
  64. 64.
    Morel-Maroger L, Kanfer A, Solez K, Sraer JD, Richet G. Prognostic importance of vascular lesions in acute renal failure with miroangiopathic hemolytic anemia (hemolytic-uremic syndrome): Clinicopathologic study in 20 adults. Kidney Int 15: 548–558, 1979.PubMedCrossRefGoogle Scholar
  65. 65.
    Levy M, Gagnadoux MF, Habib R. Pathology of hemolytic uremic syndrome in children: In Hemostasis, Prostaglandins and Renal Disease, Remuzzi G, Mecca G, de Gaetano G (eds). New York Raven Press, 1980, pp. 383–397.Google Scholar
  66. 66.
    Hoyer JR, Michael AF, Hoyer LW. Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases. J Clin Invest 53: 1375–1384, 1974.PubMedCrossRefGoogle Scholar
  67. 67.
    Ford PM, Levison DA, Down PF, McConnel JB. Clinicopathological spectrum of late post-partum renal failure: Two contrasting cases. J Clin Path 29: 101–110, 1976.PubMedCrossRefGoogle Scholar
  68. 68.
    Metz J. Observations on the mechanism of the hematological changes in the hemolytic uremic syndrome of infancy. Brit J Haemat 23(suppl): 53–59, 1972.PubMedCrossRefGoogle Scholar
  69. 69.
    Kaplan BS, Fong JSC. Platelet aggregation in hemolytic uremic syndrome. Lancet 1: 46, 1980.PubMedCrossRefGoogle Scholar
  70. 70.
    George CRP, Slichter SJ, Quadracci LJ, Striker GE, Harker LA. A kinetic evaluation of hemostasis in renal disease. N Engl J Med 291: 1111–1115, 1974.PubMedCrossRefGoogle Scholar
  71. 71.
    Avalos JS, Vitacco M, Molinas F, Penalver J, Gianantonio CA. Coagulation studies in the hemolytic-uremic syndrome. J Pediat 76: 538–548, 1970.PubMedCrossRefGoogle Scholar
  72. 72.
    Willoughby MLN, Murphay AV, McMorris S, Jewell FG. Coagulation studies in the hemolytic uremic syndrome. Arch Dis Child 47: 766–771, 1972.PubMedCrossRefGoogle Scholar
  73. 73.
    Brandt P, Jesperson J, Gregersen G. Post-partum hemolytic-uremic syndrome treated with anti-thrombin-III. Nephron 27: 15–18, 1981.PubMedCrossRefGoogle Scholar
  74. 74.
    Kwan HC. Role of fibrinolysis in thrombotic thrombocytopenic purpura. Semin Thrombos Hemostas 6: 395–400, 1980.CrossRefGoogle Scholar
  75. 75.
    Josso F, Dosne AM. Les syndromes de défibrination experimentaux. Nouv Rev Fr Hemat 8: 35–44, 1968.Google Scholar
  76. 76.
    Remuzzi G, Misiani R, Marchesi D, Livio M, Mecca G, de Gaetano G, Donati MB. Hemolytic-uremic syndrome: Deficiency of plasma factor(s) regulating prostacyclin activity. Lancet 2: 871–872, 1978.PubMedCrossRefGoogle Scholar
  77. 77.
    Remuzzi G, Misiani R, Marchesi D, Livio M, Mecca G, de Gaetano G, Donati MB. Treatment of the hemolytic uremic syndrome with plasma. Clin Nephrol 12: 279–284, 1979.PubMedGoogle Scholar
  78. 78.
    Donati MB, Misiani R, Marchesi D, Livio M, Mecca G, Remuzzi G, de Gaetano G. Hemolytic uremic syndrome, Prostaglandins and plasma factors. In Hemostasis, Prostaglandins and Renal Disease, Remuzzi G, Mecca G, de Gaetano G (eds). New York: Raven Press, 1980, pp. 283–290.Google Scholar
  79. 79.
    Remuzzi G, Imberti L, de Gaetano G. Prostacyclin deficiency in thrombotic microangiopathy. Lancet 2: 1422–1423, 1981.PubMedCrossRefGoogle Scholar
  80. 80.
    Machin SJ, Defreyn G, Chamone DAF, Vermylen J. Plasma 6-Keto-PGF-1-alpha levels after plasma exchange in thrombotic thrombocytopenic purpura. Lancet 1: 661, 1980.PubMedCrossRefGoogle Scholar
  81. 81.
    Chen YC, McLeod B, Hall ER, Wu KN. Accelerated prostacyclin degradation in thrombotic thrombocytopenic purpura. Lancet 2: 267–269, 1981.PubMedCrossRefGoogle Scholar
  82. 82.
    Lee SH, Wainscoat JS, Zeitlin H, Bolton FG, Leaver HA, Seawright A, Preece JM. Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura. Brit Med J 283: 1351–1352, 1981.CrossRefGoogle Scholar
  83. 83.
    Myburgh JA, Cohen I, Gecelter I, Myers AM, Abrahams C, Furman KI, Goldberg B, van Blerk PJP. Hyperacute rejection in human-kidney allografts-Shwartzman or Arthus reaction? N Engl J Med 281: 131–135, 1969.PubMedCrossRefGoogle Scholar
  84. 84.
    Starzl TE, Boehmig HJ, Amemiya H, Wilson CB, Dixon FJ, Giles GR, Simpson KM, Halfrimson CG. Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med 283: 384–390, 1970.CrossRefGoogle Scholar
  85. 85.
    Kincaid-Smith P. The pathogenesis of the vascular and glomerular lesions of rejection in renal allografts and their modification by antithrombic and anticoagulant drugs. Austral Ann Med 19: 1–14, 1970.Google Scholar
  86. 86.
    Callard P, Bedrossian J, Idatte JM, Belair MF, Grossetete J, Mandet Ch, Bariety J. Les lésions artérielles au cours des phénomènes de rejets des allogreffes rénales. In Actualités Néphrologiques de l’Hopital Necker. Paris: Flammarion, pp. 165–185.Google Scholar
  87. 87.
    Rosenberg JC, Hawkins E, Mammen E, Palutke M, Riddle J, Rosenberg B. Hyperacute rejection of heterografts: Studies of pig to dog renal transplants. In Coagulation Problems in Transplanted Organs, von Kaulla KN (ed). Springfield: Charles C Thomas, 1972, pp. 107–155.Google Scholar
  88. 88.
    Beleil OM, Lecky JW, Stanley TM, Mittal KK, Olmsted WW, Kaufman JJ. Protective value of heparin in hyperacute rejection of renal allografts in presensitized dogs. Invest Urol 10: 318–326, 1973.PubMedGoogle Scholar
  89. 89.
    Shons AR, Najarian JS. Modification of xenograft rejection by aspirin, dextran, and crinanserin: The importance of platelets in hyperacute rejection. Transplant Proc 6: 435–440, 1974.PubMedGoogle Scholar
  90. 90.
    Myhre-Jensen O, Lund B. Fibrinolytic activity of renal transplants in rabbits; relation to graft thrombosis and necrosis. Acta Path Microbiol Scand Section A 80: 651–658, 1972.Google Scholar
  91. 91.
    Ruggeri ZM. Endothelium, Factor VIII, von Willebrand Factor and renal diseases. In Hemostasis Prostaglandins and Renal Disease, Remuzzi G, Mecca G, de Gaetano G. New York: Raven Press, 1980, pp. 11–20.Google Scholar
  92. 92.
    Colman RW, Braun WE, Busch GJ, Dammin GJ, Merrill JP. Coagulation studies in the hyperacute and other forms of renal allograft rejection. N Engl J Med 281: 685–691, 1969.PubMedCrossRefGoogle Scholar
  93. 93.
    Porter KA, Dossetor JB, Marchioro TL, Peart WS, Rendall JM, Starzl TE, Terasaki PI. Human renal transplants. Lab Invest 16: 153–181, 1967.PubMedGoogle Scholar
  94. 94.
    Bergstein JM, Michael AF. Cortical fibrinolytic activity in normal and diseased human kidneys. J Lab Clin Med 70: 701–709, 1972.Google Scholar
  95. 95.
    Morozumi K, Yoshida A, Fujinami T, Watanabe Y. Studies on local fibrinolytic activity of the kidney in rejection of human renal allograft. Abstract of 8th International Congress of Nephrology, Athens, 1981, p. 470.Google Scholar
  96. 96.
    Antoine B, Neveu T, Ward PD. La fibrinurie au cours de la transplantation rénale chez l’homme. Rev Fr Et Clin Biol 14: 744–754, 1969.Google Scholar
  97. 97.
    Shah BC, Ambrus JL, Mink IB, Albert DJ, Sampson D, Murphy GP. Fibrin degradation products in renal parenchymal disease states and renal transplant patients. Transplantation 14: 705–710, 1972.PubMedCrossRefGoogle Scholar
  98. 98.
    Hulme B, Pitcher PM. Rapid latex-screening text for detection of fibrin/fibrinogen degradation products in urine after renal transplantation. Lancet 1: 6–10, 1973.PubMedCrossRefGoogle Scholar
  99. 99.
    Bennett NM, Bennett D, Holland NH, Luke RG. Serum fibrin degradation products in the diagnosis of transplantation rejection. Transplantation 14: 311–316, 1972.PubMedCrossRefGoogle Scholar
  100. 100.
    Hardman MR, Eitjes-van Overbeek, van Velzen AJM. Early detection of kidney transplant rejections with autologous radiolabeled blood cells: Preliminary results. In Hemostasis, Prostaglandins, and Renal Disease, Remuzzi G, Mecca G, de Gaetano G. New York: Raven Press, 1980, pp. 363–367.Google Scholar
  101. 101.
    Nicolls FA, Mac Leod A, Smith F. Indium-labeled platelet scanning after renal transplanation. Kidney Int 19: 619, 1981.CrossRefGoogle Scholar
  102. 102.
    Leithner C, Sinzinger H, Schwaez M. Prostacyclin reduces platelet deposition and prolongs platelet life span in transplant rejection. Abstracts of the 8th International Congress of Nephrology, Athens, 1981, p 453.Google Scholar
  103. 103.
    Anderson M, Dewar P, Fleming LB, Hacking PM, Morley AR, Murray S, Swinney J, Taylor RMR, Uldall PR, Wardle EN. A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection. Clin Nephrol 2: 93–99, 1974.PubMedGoogle Scholar
  104. 104.
    Kanfer A, Delarue F, Languille T. Transient platelet factor 3 activation during human renal allograft rejection. Transplantation 18: 78–81, 1974.PubMedCrossRefGoogle Scholar
  105. 105.
    Foegh ML, Zmudka M, Cooley C, Winchester JF, Hekfrich GB, Ramwell PW, Schreiner GE. Urine i-TXB2 in renal allograft rejection. Lancet 2: 431–434, 1981.PubMedCrossRefGoogle Scholar
  106. 106.
    Humphrey JH, Jaques R. The release of histamine and 5-hydroxy-tryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J Physiol 128: 9–27, 1955.PubMedGoogle Scholar
  107. 107.
    Hollenberg NK, Retik AB, Rosen SM, Murray JE, Merrill JP. The role of vasoconstriction in the ischemia of renal allograft rejection. Transplantation 6: 59–69, 1968.PubMedCrossRefGoogle Scholar
  108. 108.
    Eknoyan G, Wacksman SJ, Glueck HI, Will JJ. Platelet function in renal failure. N Engl J Med 280: 677–681, 1969.PubMedCrossRefGoogle Scholar
  109. 109.
    Larsson SO, Hedner U, Nilsson IM. On coagulation and fibrinolysis in acute renal insufficiency. Acta Med Scand 189: 443–451, 1971.PubMedCrossRefGoogle Scholar
  110. 110.
    Kleinknecht D, Jungers P, Chanard J, Barbanel C, Ganeval D. Uremic and non uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int 1: 190–196, 1972.PubMedCrossRefGoogle Scholar
  111. 111.
    Conger JD. A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 15: 1056–1063, 1975.PubMedCrossRefGoogle Scholar
  112. 112.
    Castaldi PA, Rozenberg MC, Stewart JH. The bleeding disorder of uremia. Lancet 2: 66–69, 1966.PubMedCrossRefGoogle Scholar
  113. 113.
    Rabiner SF, Hrodek O: Platelet factor 3 in normal subjects and patients with renal failure. J Clin Invest 47: 901–902, 1968.PubMedCrossRefGoogle Scholar
  114. 114.
    Remuzzi G, Marchesi D, Cavenaghi AE, Livio M, Donati MB, de Gaetano G, Mecca G. Bleeding in renal failure: A possible role of vascular prostacyclin (PGl2). Clin Nephrol 12: 127–131, 1979.PubMedGoogle Scholar
  115. 115.
    Rabiner SF, Molinas F. The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation in patients with renal failure. Amer J Med 49: 346–351, 1970.PubMedCrossRefGoogle Scholar
  116. 116.
    Horowitz HI, Stein IM, Cohen BD, White JG. Further studies on the platelet-inhibiting effect of guanidinosuccinic acid and its role in uremic bleeding. Amer J Med 49: 336–345, 1970.PubMedCrossRefGoogle Scholar
  117. 117.
    Kanfer A, Vandewalle A, Beaufils M, Delarue F, Sraer JD. Enhanced antiplasmin activity in acute renal failure. Brit Med J 4: 195–197, 1975.PubMedCrossRefGoogle Scholar
  118. 118.
    McMurray SD, Luft FC, Maxwell DR, Hamburger RJ, Futty D, Swed JJ, Lavelle KJ, Kleit SA. Prevailing patterns and predictor variables in patients with acute tubular necrosis. Arch Intern Med 138: 950–955, 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Alain Kanfer

There are no affiliations available

Personalised recommendations